TGACBD A Public Consultation on the Scheduling of Cannabidiol in Australia Friendly Aussie Buds In 2023, the FDA banned 19 peptides from compounding pharmacies. No specific safety incident. No clear signal. Just a regulatory decision that pushed millions of patients toward gray market suppliers and overseas The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Some peptides are FDA approved drugs. Some are legal supplements. Some are neither. The same word, peptide, covers all three categories. The regulatory status of the specific compound is what determines legality.